Fabián Darío Arias Rodríguez, Mercedes Larenas, Santiago Paredes, Guillermina Giuliano, Andrés López-Cortés, Juan S Izquierdo-Condoy
{"title":"Expanding the diagnostic spectrum of malignant otitis externa: a case report of proteus infection in a non-immunosuppressed patient.","authors":"Fabián Darío Arias Rodríguez, Mercedes Larenas, Santiago Paredes, Guillermina Giuliano, Andrés López-Cortés, Juan S Izquierdo-Condoy","doi":"10.3389/fmed.2025.1577525","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Malignant otitis externa (MOE) is a severe and potentially life-threatening infection of the external auditory canal, most frequently caused by <i>Pseudomonas aeruginosa</i>. Although typically seen in immunocompromised individuals-especially those with diabetes mellitus-up to 45% of cases have been reported in non-diabetic patients, highlighting the importance of recognizing atypical presentations. Rare pathogens, such as <i>Proteus mirabilis</i>, have been identified in only a few documented cases. Early diagnosis and prompt intervention are essential to prevent serious complications, including osteomyelitis and intracranial extension.</p><p><strong>Objectives: </strong>This report describes a really uncommon case of malignant otitis externa caused by <i>P. mirabilis</i> in a non-diabetic, immunocompetent patient.</p><p><strong>Case presentation: </strong>A 53-year-old male with no relevant medical history presented with a four-month history of left-sided otorrhea, otalgia, and preauricular pain. Examination and imaging revealed purulent discharge and bone erosion, suggestive of MOE. Empirical treatment with amoxicillin/clavulanic acid was ineffective. Culture identified <i>Proteus mirabilis</i>, resistant to multiple antibiotics but sensitive to piperacillin/tazobactam, which was administered with supportive care. After 17 days of intravenous therapy, the patient improved and was discharged on oral ciprofloxacin to complete a three-month course. Follow-up confirmed clinical resolution without recurrence.</p><p><strong>Conclusion: </strong>This case report highlights an exceptionally rare occurrence of MEO caused by <i>P. mirabilis</i> in an immunocompetent, non-diabetic patient. It emphasizes the need to consider uncommon pathogens and atypical clinical profiles in MOE. Early diagnosis, microbiological confirmation, and tailored antimicrobial therapy were critical for favorable outcomes.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1577525"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263653/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1577525","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Malignant otitis externa (MOE) is a severe and potentially life-threatening infection of the external auditory canal, most frequently caused by Pseudomonas aeruginosa. Although typically seen in immunocompromised individuals-especially those with diabetes mellitus-up to 45% of cases have been reported in non-diabetic patients, highlighting the importance of recognizing atypical presentations. Rare pathogens, such as Proteus mirabilis, have been identified in only a few documented cases. Early diagnosis and prompt intervention are essential to prevent serious complications, including osteomyelitis and intracranial extension.
Objectives: This report describes a really uncommon case of malignant otitis externa caused by P. mirabilis in a non-diabetic, immunocompetent patient.
Case presentation: A 53-year-old male with no relevant medical history presented with a four-month history of left-sided otorrhea, otalgia, and preauricular pain. Examination and imaging revealed purulent discharge and bone erosion, suggestive of MOE. Empirical treatment with amoxicillin/clavulanic acid was ineffective. Culture identified Proteus mirabilis, resistant to multiple antibiotics but sensitive to piperacillin/tazobactam, which was administered with supportive care. After 17 days of intravenous therapy, the patient improved and was discharged on oral ciprofloxacin to complete a three-month course. Follow-up confirmed clinical resolution without recurrence.
Conclusion: This case report highlights an exceptionally rare occurrence of MEO caused by P. mirabilis in an immunocompetent, non-diabetic patient. It emphasizes the need to consider uncommon pathogens and atypical clinical profiles in MOE. Early diagnosis, microbiological confirmation, and tailored antimicrobial therapy were critical for favorable outcomes.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world